Additionally, Rajamaki et al. identified hypomethylation and subsequent overexpression of OSMR in inflammatory bowel disease-associated CRC (IBD-CRC) patients, which may result in EMT of CRC cells and promote resistance to anti-TNFα therapies (mentioned in the Inflammatory Bowel Disease section) (154). This evidence concerns the gene OSMR and inflammatory bowel disease.